RB
Robert Burns HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
122
Avg Return
Past Year
Past Year
39%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
93.3%
Neutral
6.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Financials
Asset Management
Healthcare
Biotechnology
Drug Manufacturers - General
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Reiterated
| $2 |
50%
downside
| 2 | – |
–
| 3 Nov ‘25 7 months ago |
|
|
|
Buy
Upgraded
| $5 |
156%
upside
| 1 | -9.3% |
0
%
| 31 Oct ‘25 7 months ago |
|
|
|
Buy
Maintained
| $3 |
13%
upside
| 1 | +34% |
0
%
| 27 Oct ‘25 7 months ago |
|
|
|
Buy
Upgraded
| $12 |
36%
upside
| 4 | -44% |
0
%
| 27 Oct ‘25 7 months ago |
|
|
|
Buy
Maintained
| $7 |
554%
upside
| 2 | +92% |
0
%
| 16 Oct ‘25 8 months ago |
|
|
|
Buy
Reiterated
| $5 |
19%
upside
| 3 | +101% |
0
%
| 23 Sep ‘25 8 months ago |
|
|
|
Buy
Maintained
| $14 |
6%
downside
| 1 | +194% |
0
%
| 26 Aug ‘25 9 months ago |
|
|
|
Buy
Maintained
| $40 |
85%
upside
| 3 | +28% |
0
%
| 22 Aug ‘25 9 months ago |
|
|
|
Buy
Maintained
| $10 |
481%
upside
| 2 | +16% |
0
%
| 11 Aug ‘25 10 months ago |
|
|
|
Neutral
Downgraded
| $8.60 |
0%
downside
| 3 | +46% |
0
%
| 6 Aug ‘25 10 months ago |
|
|
|
Buy
Maintained
| $48 |
12%
upside
| 3 | +11% |
0
%
| 2 Jul ‘25 11 months ago |
|